Given that PIK3CA is a key component of the PI3K/AKT pathway, it is not surprising that examinations of alterations in 10 classic cancer-associated pathways31 revealed that this pathway as the most frequently altered, affecting 67.7% of the patients (Figure 1A). The gene discussed is AKT1; the disease is cancer.